Abstract
AbstractUrsolic acid has been evaluated for its choleretic, anticholestatic and hepatoprotective activities in rats. It produced a dose‐dependent (5–20 mg/kg) choleretic effect. Significant anticholestatic activity (27.9–100%) was observed against paracetamol (2.0 g/kg) induced cholestasis. The compound also showed a marked hepatoprotective activity against paracetamol and galactosamine (800 mg/kg) induced hepatotoxicity by reversing the altered values in viability of the isolated hepatocytes and the altered biochemical liver and serum parameters. The activity of ursolic acid compared well with the known hepatoprotective drug, silymarin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
